EUVIMEDEUVIMED entdecken
Crossref

EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION

Yosr Ziadi, Taehwan Park

Value in Health · 2026-06 · 29 (6) · S128

DOI: 10.1016/j.jval.2026.03.635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Yosr Ziadi und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ziadi, Y., & Park, T. (2026). EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION. Value in Health, 29(6), S128. https://doi.org/10.1016/j.jval.2026.03.635

Vancouver

Ziadi Y, Park T. EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION. Value in Health. 2026;29(6):S128. doi:10.1016/j.jval.2026.03.635

BibTeX
@article{Ziadi2026,
  author = {Ziadi, Yosr and Park, Taehwan},
  title = {EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION},
  journal = {Value in Health},
  year = {2026},
  volume = {29},
  number = {6},
  pages = {S128},
  doi = {10.1016/j.jval.2026.03.635}
}
Kostenlos starten →